ChromaCode’s EUA Expanded by FDA for High-Throughput HDPCR SARS-CoV-2 Real-Time PCR Assay
Over six million tests have been performed and analyzed using the HDPCR SARS-CoV-2 EUA assay and ChromaCode Cloud
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Feb 22
Over six million tests have been performed and analyzed using the HDPCR SARS-CoV-2 EUA assay and ChromaCode Cloud
24 Feb 22
LIVOx is the first monitoring device to non-invasively monitor sepsis by detecting a key indicator of septic shock
23 Feb 22
Q-POC SARS-CoV-2 is a rapid, simple to use, portable, sample to answer PCR test that delivers accurate PCR…
23 Feb 22
The debrider is designed to simplify patient care in the clinic and allows less invasive procedures in any…
22 Feb 22
The diagnostics company has developed its rapid Covid-19 test by leveraging unique qSTAR technology, delivers results within 20…
22 Feb 22
Foundation Medicine’s tissue-based comprehensive genomic profiling test is the first and only FDA approved CDx to identifying patients…
22 Feb 22
The system at Tongji Hospital will feature Mevion’s industry leading HYPERSCAN® Pencil Beam Scanning (PBS) technology, coupled with…
22 Feb 22
The 28,589-square-foot facility is located at 185 Constitution Drive in Menlo Park. The new lab will double the…
21 Feb 22
The Series A financing round was led by an affiliate of Bernie Marcus and Georgia Research Alliance
21 Feb 22
The acquisition includes clinical data pipeline, machine learning engines, AI powered radiology workflow management and analytics tools, in…